Vaccine trials for possible fourth dose in fall with Andrea Garcia, JD, MPH | COVID-19 Update

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering updates from FDA’s vaccine advisory committee meeting regarding a revised version of the COVID vaccine for fall, the FDA suspending use of a monoclonal antibody drug by GlaxoSmithKline known as sotrovimab to treat high-risk COVID-19 patients in the U.S. because it’s unlikely to be effective against BA.2, and a clinical trial published in NEJM confirms that the anti-parasitic drug, ivermectin, showed no sign of alleviating COVID.

0:00 AMA COVID-19 Update for April 13, 2022
0:29 FDA vaccine advisory committee updates
1:50 Are vaccine trials for the fall underway?
3:09 Which COVID variant will dominate in the fall?
4:09 Federal appeals court reversed decision blocking COVID vaccine mandate for federal workers
5:10 Congress stalls on $10 billion COVID response package
6:21 New virus cases have increased recently in about half of all states and territories
7:34 COVID cases have doubled in Washington D.C. and have risen about 60% in New York City
8:10 Surge in high-profile cases may not reflect true spread of the virus; Philadelphia is reinstating indoor mask mandates
9:49 Hospitalizations from COVID have fallen over the past two weeks
10:31 Clinical trial confirms ivermectin showed no sign of alleviating COVID
11:47 FDA suspends use of sotrovimab to treat high-risk COVID-19 patients

Stay up to date on the latest information about the pandemic: https://ama-assn.org/covid-19-resources.
Visit the COVID-19 Daily Video Updates page for more videos in this series: https://ama-assn.org/covid-19-videos.